(News Bulletin 247) – Pixium Vision shares consolidated on Monday following their spectacular surge of more than 300% on Friday, which brought the value back above the 10-cent threshold and to multi-month highs.
In the middle of the day, the title of the bioelectronics company – which develops bionic vision systems for patients who have lost their sight – drops close to 10%.
Pixium had soared nearly 320% in huge trading volumes on Friday as investors hailed the US FDA’s ‘breakthrough’ device status for its Prima system in the treatment of dry AMD.
In a statement on Monday, the company said it was pleased with the increased market interest, citing “remarkable success” illustrating its ability to achieve its goals.
Following the surge in the stock market, ESGO – an American investor specializing in health – has also decided to convert bonds redeemable in cash and in new shares (ORNAN) for a total amount of 1.6 million euros. euros, making him a major shareholder of Pixium.
But the company recalls that ESGO does not intend to remain a major shareholder and that the fund has informed it of its intention to dispose of its shares ‘in a responsible manner’ so as not to have a significant impact on the market. share price.
Copyright (c) 2023 News Bulletin 247. All rights reserved.
I have over 8 years of experience working in the news industry. I have worked as a reporter, editor, and now managing editor at 247 News Agency. I am responsible for the day-to-day operations of the news website and overseeing all of the content that is published. I also write a column for the website, covering mostly market news.
